I have been here since SGBY, as many of us have. We didn’t expect the testing to take so long to go into effect. Oregon had issues of over supply from too many cultivators which is IMO why revenues were low. We spent a lot of dilution on labs that won’t show revenue until Q1 (because of laws). I understand we needed to mark our territory and it’s our fault for buying too early essentially. But I know not to follow this until the K at minimum or Q1 in February really. I’m loaded up on all the shares so I wait. But it’s a good time for others to accumulate slowly as they catch on to the brand. As we open in more states and testing is mandated well eventually have more followers. But as Tar has said forever, revenues must keep up with dilution for evaluation.
News 
Market Data 
Discover 
